This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Cauda epithelial cell
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Leukemia cell (K562)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Mast cell (HMC-1)
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Multiple myeloma cells (U266)
Serum
By sample status
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_Exiqon
Survived under long-term hypoxia
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-503-5p
MIMAT0002874
0.0e+0
3.1e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
4.1e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
9.4e-2
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
3.9e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
2.1e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
3.7e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
3.7e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
2.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
4.3e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.3e-2
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
4.4e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
1.3e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
4.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.2e-2
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
4.9e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.0e-2
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
1.1e-7
4.9e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
2.7e-7
4.9e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
1.5e-1
Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.2e-2
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.1e-2
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
8.1e-2
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
0.0e+0
7.9e-2
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
9.7e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
5.1e-3
4.9e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000183_1
34
/
0
/
34
hsa-miR-503-5p
MIMAT0002874
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000183_1
34
/
0
/
34
[1]